Mark M. Webber
2007
In 2007, Mark M. Webber earned a total compensation of $532.9K as Former Chief Financial Officer at Sarepta Therapeutics, a 5% decrease compared to previous year.
Compensation breakdown
Bonus | $27,500 |
---|---|
Option Awards | $261,372 |
Salary | $235,000 |
Other | $9,000 |
Total | $532,872 |
Webber received $261.4K in option awards, accounting for 49% of the total pay in 2007.
Webber also received $27.5K in bonus, $235K in salary and $9K in other compensation.
Rankings
In 2007, Mark M. Webber's compensation ranked 5,863rd out of 8,700 executives tracked by ExecPay. In other words, Webber earned more than 32.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,863 out of 8,700 | 33rd |
Division Manufacturing | 2,203 out of 3,314 | 34th |
Major group Chemicals And Allied Products | 483 out of 746 | 35th |
Industry group Drugs | 331 out of 546 | 39th |
Industry Pharmaceutical Preparations | 241 out of 364 | 34th |
Source: SEC filing on April 14, 2009.
Webber's colleagues
We found five more compensation records of executives who worked with Mark M. Webber at Sarepta Therapeutics in 2007.
2007
Alan Timmins
Sarepta Therapeutics
Chief Operating Officer
2007
K Forrest
Sarepta Therapeutics
Chief Executive Officer
2007
Patrick Iversen
Sarepta Therapeutics
Senior Vice President of Strategic Alliances
2007
Peter O'Hanley
Sarepta Therapeutics
SVP of Clinical Development and Regulatory Affairs
2007
Dwight Weller
Sarepta Therapeutics